查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1938965

2026年全球药物传输设备市场报告

Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物输送装置的市场规模显着成长，预计将从2025年的959.9亿美元成长到2026年的1,021.5亿美元，复合年增长率为6.4%。过去几年的成长归因于慢性病盛行率上升、注射疗法的推广、院内给药增加、输液装置的使用日益普及以及製剂技术的进步等因素。

预计未来几年，药物输送设备市场将保持强劲成长，到2030年市场规模将达到1,289.4亿美元，复合年增长率（CAGR）为6.0%。预测期内的成长要素包括：居家药物输送的普及率不断提高、个人化医疗投资增加、生物製药和生物类似药的扩张、对互联输送设备的需求不断增长以及数位健康平台的日益融合。预测期内的主要趋势包括：智慧型药物输送设备的普及率不断提高、自行注射系统的普及率不断提高、对缓释技术的需求不断增长、可穿戴药物输送平台的扩张以及对以患者为中心的设计的日益重视。

预计未来几年，不断增长的医疗费用支出将推动药物输送设备市场的成长。医疗费用支出是指用于医疗保健相关服务和产品的总资金，包括医院、医生、护理、处方药和公共卫生措施。人口老化、慢性病增加、医疗技术进步以及医疗服务和药物成本上涨等因素导致医疗保健医疗费用支出不断增加。不断增长的医疗保健支出支持药物输送设备的发展，因为它能够增加对研发和创新的投资，并促进先进技术的应用，从而提高治疗效果和改善患者预后。例如，根据英国政府机构国家统计局 (ONS) 的数据，截至 2024 年 5 月，英国的医疗费用支出预计将在 2023 年达到约 3,790 亿美元（2,920 亿英镑）。与 2022 年相比，这相当于名目成长 5.6%，远高于上年度0.9% 的成长率。因此，医疗费用支出不断增长，促进了药物输送设备市场的成长。

药物递送装置市场的主要企业正致力于开发先进的解决方案，例如定向口服释放胶囊，以提高治疗效果并减少全身副作用。定向口服释放胶囊旨在耐受胃部的酸性环境，并在胃肠道的特定部位精准释放活性成分，从而提高生物利用度并实现局部治疗。例如，总部位于德国的特种化学品和生命科学公司赢创于2024年9月推出了EUDRACAP结肠胶囊，该胶囊旨在将敏感的活性成分递送至髂骨区域。这些胶囊能够递送活体生物製药、口服生物製药、胜肽、蛋白质和核苷酸，并透过客製化设计的EUDRAGIT包衣保持其稳定性。 EUDRACAP结肠胶囊采用即用型设计，简化了製剂开发流程，降低了开发复杂性，并加快了产品上市速度。这项进展扩展了赢创的EUDRACAP平台，并增强了其用于先进口服药物递送的系统解决方案组合。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药物输送设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧与自主智能
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 智慧型药物传输装置的应用日益普及
    • 自行注射系统日益普及
    • 缓释技术的需求不断成长
    • 扩展穿戴式药物输送平台
    • 越来越重视以病人为中心的设计

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 门诊手术中心
  • 居家照护提供者
  • 专科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药物输送设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球药物传输设备市场规模、比较及成长率分析
  • 全球药物传输设备市场表现：规模与成长，2020-2025年
  • 全球药物输送设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过行政途径
  • 口服给药、注射给药、局部给药、眼部给药、肺部给药、鼻腔给药、粘膜给药、植入式给药
  • 患者照护场所
  • 医院、诊断中心、门诊手术中心/诊所、居家医疗机构和其他患者照护场所
  • 透过使用
  • 癌症、感染疾病、呼吸系统疾病、糖尿病、心血管疾病、自体免疫疾病、中枢神经系统疾病及其他适应症
  • 按类型细分：口服给药
  • 锭剂和胶囊、口腔喷雾、口服液、口溶锭
  • 按类型细分：注射给药
  • 注射器（手动和自动丢弃式）、管瓶和药筒、注射笔、输液泵
  • 按类型细分：局部药物输送
  • 乳膏和软膏、经皮吸收贴片、凝胶和洗剂、粉剂
  • 按类型细分：眼科药物递送
  • 眼药水、眼内植入物、隐形眼镜给药系统
  • 按类型细分：肺部给药
  • 定量喷雾吸入器（MDI）、干粉吸入器（DPI）、雾化器
  • 按类型细分：鼻内给药
  • 鼻喷剂、鼻粉和滴鼻剂
  • 按类型细分：粘膜给药
  • 口腔黏膜片、舌下片、黏膜黏附膜
  • 按类型细分：植入式药物传输系统
  • 药物植入式装置、可生物降解植入、储液囊型植入

第十章 区域与国家分析

  • 全球药物传输设备市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球药物输送设备市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物输送装置市场：竞争格局及市场占有率（2024年）
  • 药物输送设备市场：公司估值矩阵
  • 药物输送设备市场：公司概况
    • Becton Dickinson and Company
    • Baxter International
    • B. Braun Melsungen AG
    • Catalent
    • West Pharmaceutical Services Inc.

第37章：其他领先和创新企业

  • Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物输送设备市场：提供新机会的国家
  • 2030年药物输送设备市场：充满新机会的细分市场
  • 2030年药物传输设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME2MDDDE01_G26Q1

Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

Tariffs are impacting the drug delivery devices market by increasing costs of imported polymers, electronic components, precision molds, sensors, and infusion system parts used across injectables, inhalers, and implantable devices. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces export-related cost pressures. These tariffs are raising device prices and slowing procurement cycles. However, they are also driving localization of device manufacturing, regional supplier development, and innovation in cost-efficient delivery technologies.

The drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market size has grown strongly in recent years. It will grow from $95.99 billion in 2025 to $102.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable therapies, growth in hospital-based drug administration, increasing use of infusion devices, advancements in pharmaceutical formulations.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing adoption of home-based drug delivery, rising investments in personalized medicine, expansion of biologics and biosimilars, growing demand for connected delivery devices, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising use of self-administration injection systems, growing demand for controlled release technologies, expansion of wearable drug delivery platforms, enhanced focus on patient-centric designs.

Rising healthcare expenditure is anticipated to drive the growth of the drug delivery devices market in the coming years. Healthcare spending refers to the total financial resources allocated to health-related services and products, including expenditures on hospitals, physicians, nursing care, prescription medicines, and public health initiatives. Healthcare spending is increasing due to factors such as an aging population, the growing prevalence of chronic diseases, advancements in medical technologies, and escalating costs of healthcare services and pharmaceuticals. Higher healthcare expenditure supports the development of drug delivery devices by enabling greater investment in research, innovation, and the adoption of advanced technologies that enhance treatment effectiveness and patient outcomes. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the United Kingdom reached approximately $379 billion (£292 billion) in 2023. This represented a 5.6% nominal increase compared with 2022, a notable rise from the 0.9% growth recorded in the previous year. Therefore, increasing healthcare spending is contributing to the growth of the drug delivery devices market.

Leading players operating in the drug delivery devices market are focusing on the development of advanced solutions, such as targeted oral release capsules, to improve treatment efficacy and reduce systemic side effects. Targeted oral release capsules are designed to withstand the acidic conditions of the stomach and release active ingredients accurately in specific regions of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, introduced its EUDRACAP colon capsules, which are intended for the delivery of sensitive active substances to the ileo-colonic region. These capsules enable the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while maintaining their stability through customized EUDRAGIT coatings. The EUDRACAP colon capsules also simplify formulation development with a ready-to-fill design and accelerate time to market by reducing development complexity. This advancement expands Evonik's EUDRACAP platform and reinforces its system solutions portfolio for advanced oral drug delivery.

In October 2024, Aptar Pharma, a US-based supplier of drug delivery systems and active material science solutions, acquired the device technology assets of SipNose Nasal Delivery Systems for an undisclosed sum. Through this acquisition, Aptar seeks to broaden its intranasal drug delivery portfolio, strengthen its nose-to-brain delivery capabilities, and accelerate innovation in central nervous system therapeutic platforms. SipNose, an Israel-based company, develops intranasal delivery devices for both liquid and dry powder formulations, enabling local, systemic, and direct brain delivery of active ingredients.

Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery
  • 2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Other Patient Care Settings
  • 3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Other Applications
  • Subsegments:
  • 1) By Oral Drug Delivery: Tablets and Capsules; Oral Sprays; Oral Liquids; Oral Disintegrating Tablets
  • 2) By Injectable Drug Delivery: Syringes (manual and auto-disable); Vials and Cartridges; Pen Injectors; Infusion Pumps
  • 3) By Topical Drug Delivery: Creams and Ointments; Transdermal Patches; Gels and Lotions; Powders
  • 4) By Ocular Drug Delivery: Eye Drops; Ocular Inserts; Contact Lens Drug Delivery Systems
  • 5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers
  • 6) By Nasal Drug Delivery: Nasal Sprays; Nasal Powders; Nasal Drops
  • 7) By Transmucosal Drug Delivery: Buccal Tablets; Sublingual Tablets; Mucoadhesive Films
  • 8) By Implantable Drug Delivery: Drug-Implantable Devices; Biodegradable Implants; Reservoir-based Implants
  • Companies Mentioned: Becton Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; West Pharmaceutical Services Inc.; Gerresheimer AG; Smiths Medical; Elcam Medical; SMC Ltd.; Injex; Ypsomed Holding AG; Nemera; H&T Presspart; Syqe Medical; Antares Pharma; Julphar; Teleflex Medical; Kedalion Therapeutics; MediPrint Ophthalmics; Sorrel Medical; Terumo Corporation; Gilero
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Drug Delivery Devices
    • 4.2.2 Rising Use Of Self-Administration Injection Systems
    • 4.2.3 Growing Demand For Controlled Release Technologies
    • 4.2.4 Expansion Of Wearable Drug Delivery Platforms
    • 4.2.5 Enhanced Focus On Patient-Centric Designs

5. Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Ambulatory Surgery Centers
  • 5.4 Home Care Providers
  • 5.5 Specialty Clinics

6. Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Delivery Devices Market Segmentation

  • 9.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
  • 9.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
  • 9.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
  • 9.4. Global Drug Delivery Devices Market, Sub-Segmentation Of Oral Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
  • 9.5. Global Drug Delivery Devices Market, Sub-Segmentation Of Injectable Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
  • 9.6. Global Drug Delivery Devices Market, Sub-Segmentation Of Topical Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
  • 9.7. Global Drug Delivery Devices Market, Sub-Segmentation Of Ocular Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
  • 9.8. Global Drug Delivery Devices Market, Sub-Segmentation Of Pulmonary Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
  • 9.9. Global Drug Delivery Devices Market, Sub-Segmentation Of Nasal Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nasal Sprays, Nasal Powders, Nasal Drops
  • 9.10. Global Drug Delivery Devices Market, Sub-Segmentation Of Transmucosal Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
  • 9.11. Global Drug Delivery Devices Market, Sub-Segmentation Of Implantable Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

10. Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Delivery Devices Market

  • 11.1. Asia-Pacific Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Delivery Devices Market

  • 12.1. China Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Delivery Devices Market

  • 13.1. India Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Delivery Devices Market

  • 14.1. Japan Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Delivery Devices Market

  • 15.1. Australia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Delivery Devices Market

  • 16.1. Indonesia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Delivery Devices Market

  • 17.1. South Korea Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Delivery Devices Market

  • 18.1. Taiwan Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Delivery Devices Market

  • 19.1. South East Asia Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Delivery Devices Market

  • 20.1. Western Europe Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Delivery Devices Market

  • 21.1. UK Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Delivery Devices Market

  • 22.1. Germany Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Delivery Devices Market

  • 23.1. France Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Delivery Devices Market

  • 24.1. Italy Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Delivery Devices Market

  • 25.1. Spain Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Delivery Devices Market

  • 26.1. Eastern Europe Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Delivery Devices Market

  • 27.1. Russia Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Delivery Devices Market

  • 28.1. North America Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Delivery Devices Market

  • 29.1. USA Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Delivery Devices Market

  • 30.1. Canada Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Delivery Devices Market

  • 31.1. South America Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Delivery Devices Market

  • 32.1. Brazil Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Delivery Devices Market

  • 33.1. Middle East Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Delivery Devices Market

  • 34.1. Africa Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Delivery Devices Market, Segmentation By Route Of Administration, Segmentation By Patient Care Setting, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Delivery Devices Market Regulatory and Investment Landscape

36. Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Delivery Devices Market Company Profiles
    • 36.3.1. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Catalent Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. West Pharmaceutical Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Drug Delivery Devices Market Other Major And Innovative Companies

  • Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical

38. Global Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Delivery Devices Market

40. Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer